News Live: USFDA issues two observations to Aurobindo Pharma’s Hyderabad unit
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

VBHC defers initial float plan

- business-standard

moneycontrol.com
2 months ago

News Live: USFDA issues two observations to Aurobindo Pharma’s Hyderabad unit

The regulator found no written procedures for production and process controls. Unit VI was inspected from August 28 to September 1. It has now issued two observations to Aurobindo Pharma’s unit VI.

Read on the original site


Nifty up 41 ends below 10,400

- business-standard

Dy CAG calls on Chief Minister

- dailyexcelsior.com

Rupee settles back

- business-standard

T N Ninan: A bone in the throat

- business-standard
Hashtags:   

News

 | 

Live

 | 

USFDA

 | 

issues

 | 

two

 | 

observations

 | 

Aurobindo

 | 

Pharma’s

 | 

Hyderabad

 |